Chlordiazepoxide hydrochloride 5 mg / clidinium bromide 2.5 mg [Librax]
RxNorm 889615
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 889615 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: chlordiazepoxide hydrochloride 5 mg / clidinium bromide 2.5 mg [Librax].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDCPrescribable
Semantic Branded Drug Component (SBDC):
Chlordiazepoxide hydrochloride 5 mg / clidinium bromide 2.5 mg [Librax]
(Atom ID: 12300262)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
ChlordiazePOXIDE hydrochloride 5 mg / clidinium bromide 2.5 mg [Librax]
(Atom ID: 12383760)
Patient Education
Chlordiazepoxide and Clidinium
The combination of chlordiazepoxide and clidinium is used along with other medications to treat peptic ulcers, irritable bowel syndrome (IBS; a condition that causes stomach pain, bloating, constipation, and diarrhea), and enterocolitis (swelling in the intestines). Chlordiazepoxide is in a class of medications called benzodiazepines. It works by decreasing abnormal electrical activity in the brain. Clidinium is in a class of medications called anticholinergics. It helps to decrease stomach spasms and cramps.
[Learn More]
* Please review the disclaimer below.